Petauri™ completes acquisition of Brightly Network's medical communications agencies
08/14/24, 12:01 PM
Location
nashvillenashvilleIndustry
biotechnology
pharmaceutical
medical
health care
health care
pharmaceutical
Petauri, a leading purpose-built pharmaceutical services platform, has announced the acquisition of four US-based firms: Bluprint Oncology, Cogency, Verascity, and Blendworks, from the Brightly Network. This acquisition further expands Petauri's capabilities and expertise in medical communications, specializing in oncology, hematology, and rare diseases across medical and commercial strategy, engagement, and education.
Company Info
Location
Nashville, Arkansas, United States
Company info
Petauri™ is a purpose-built pharmaceutical services organization. Our mission is to ensure that scientific breakthroughs reach patients with pressing medical needs by providing best-in-class, data-driven, digital-forward solutions. Petauri areas of focus include global market access, medical affairs, patient services, and data and analytics.